Precigen Inc. (PGEN)
NASDAQ: PGEN
· Real-Time Price · USD
3.25
-0.08 (-2.40%)
At close: Oct 03, 2025, 3:59 PM
3.24
-0.28%
After-hours: Oct 03, 2025, 07:36 PM EDT
-2.40% (1D)
| Bid | 3.21 |
| Market Cap | 965.86M |
| Revenue (ttm) | 4.34M |
| Net Income (ttm) | -124.5M |
| EPS (ttm) | -0.42 |
| PE Ratio (ttm) | -7.74 |
| Forward PE | -37 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 3.28 |
| Volume | 3,670,739 |
| Avg. Volume (20D) | 8,826,693 |
| Open | 3.37 |
| Previous Close | 3.33 |
| Day's Range | 3.19 - 3.37 |
| 52-Week Range | 0.65 - 5.23 |
| Beta | 1.61 |
| Ex-Dividend Date | n/a |
About PGEN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PGEN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PGEN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsPrecigen Inc. is scheduled to release its earnings on
Nov 13, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+9.15%
Precigen shares are trading higher after JMP Secur...
Unlock content with
Pro Subscription
1 month ago
+58.92%
Precigen shares are trading higher after the company announced the FDA has approved PAPZIMEOS. HC Wainwright & Co. raised its price target on the stock from 6 to $8.5.
